Back to Search
Start Over
Successful treatment with rivaroxaban for an acute pulmonary thromboembolism in a patient with primary antiphospholipid antibody syndrome
- Publication Year :
- 2019
- Publisher :
- Japanese College of Cardiology, 2019.
-
Abstract
- A 73-year-old man was admitted with sudden onset of dyspnea. Contrast-enhanced computed tomography showed acute pulmonary thromboembolism and deep vein thrombosis. He was started on the direct oral anticoagulant rivaroxaban (factor Xa inhibitor) and this resolved the thrombus. Serological analysis revealed that his risk of thrombosis was primary antiphospholipid syndrome (APS). He has remained free of recurrent venous thromboembolism (VTE) for two years while under rivaroxaban. We present a case with VTE due to APS for whom direct oral anticoagulant was effective.
- Subjects :
- medicine.medical_specialty
medicine.drug_mechanism_of_action
Deep vein
Factor Xa Inhibitor
030204 cardiovascular system & hematology
Article
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
030212 general & internal medicine
cardiovascular diseases
Thrombus
Lupus anticoagulant
Rivaroxaban
biology
business.industry
Acute pulmonary thromboembolism
medicine.disease
Thrombosis
medicine.anatomical_structure
Cardiology
biology.protein
Antibody
Cardiology and Cardiovascular Medicine
business
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....43aecaa077d48e2b9d0bc06c1726e1af